Most Popular

Check out the most popular stories and multimedia features across the site right now

Trump shadow
First Opinion

I used applied psychoanalysis to assess President Trump. The diagnosis is frightening

By Justin A. Frank

Eli Lilly insulin
Pharmalot

Insulin prices could be much lower and drug makers would still make healthy profits

By Ed Silverman

Omega 3
Health

Amarin fish oil capsule shows dramatic benefit for cardiovascular patients, potentially upending market

By Adam Feuerstein

FDA-Blood Sugar Monitor
Health

FDA approves first blood sugar monitor without finger pricks

By Associated Press

STAT Live

Webinar archive: How to interpret clinical trial results like a pro

By Sharon Begley and Adam Feuerstein

Fish oil capsules
Adam's Take

Amarin has investors buzzing about fish oil. Here’s where this biotech feel-good story goes next

By Adam Feuerstein

Puppies for sale
Health

Puppies are making people sick — and it’s people’s fault

By Helen Branswell

Bana
Exclusive

For the first time, researchers will release genetically engineered mosquitoes in Africa

By Ike Swetlitz

Surgical waste
First Opinion

The hidden harm of health care: air, water, and other pollution

By Jonathan E. Slutzman

FIREFLIES
In the Lab

To make better biomedical research tools, a grad student picks apart fireflies’ glow

By Eric Boodman

Mark Merritt
Politics

With PBMs firmly in Washington’s crosshairs, their top lobbyist steps down with no regrets

By Nicholas Florko

Adam's Take

TG Therapeutics’ credibility vanishes with blood cancer drug trial setback

By Adam Feuerstein

Ketamine Clouds
A STAT Investigation

Ketamine gives hope to patients with severe depression. But some clinics stray from the science and hype its benefits

By Megan Thielking

FDA; Drug Administration campus
Biotech

Sarepta’s gene therapy program for Duchenne resumes after clinical trial hold lifted

By Kate Sheridan

Dr. Holm Schneider
Health

‘A full rescue’: Drug injected before birth treats rare genetic disorder

By Eric Boodman

Thomas Goode
Special Report

Denied ‘life-extending opportunities’: Black patients are being left out of clinical trials amid wave of new cancer therapies

By Caroline Chen and Riley Wong — ProPublica

A depiction of Pulmonary ionocytes extending into the respiratory tract of a mouse.
In the Lab

Discovery of unknown lung cell points to new target for cystic fibrosis medicines

By Andrew Joseph

Sick Watson
Exclusive

IBM’s Watson supercomputer recommended ‘unsafe and incorrect’ cancer treatments, internal documents show

By Casey Ross and Ike Swetlitz

Rebecca genetic testing
Business

Genetic tests promised to help me achieve peak fitness. What I got was a fiasco

By Rebecca Robbins

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy